What is the treatment for Jarduance (generic name unknown) induced fungal infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Jardiance-Induced Fungal Infection

Fluconazole 200 mg (3 mg/kg) daily for 2 weeks is the recommended treatment for Jardiance-induced fungal infection, which is likely a form of symptomatic candidiasis. 1

Diagnosis and Assessment

  • Before initiating treatment, confirm the diagnosis through appropriate cultures from the affected site to identify the specific fungal pathogen 1
  • Jardiance (empagliflozin) is an SGLT2 inhibitor that can increase the risk of genital mycotic infections due to increased urinary glucose excretion 2
  • Most Jardiance-induced fungal infections are caused by Candida species, particularly Candida albicans 1
  • Assess the severity and extent of the infection to determine appropriate treatment approach 1

Treatment Algorithm

First-Line Treatment

  • For symptomatic candidiasis (most common Jardiance-induced fungal infection):
    • Fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
    • For extensive or severe infections, consider fluconazole 150-200 mg once daily for 2-4 weeks 2

Alternative Treatments (if fluconazole resistance is suspected or confirmed)

  • Amphotericin B deoxycholate (AmB-d) 0.3-0.6 mg/kg for 1-7 days 1
  • Flucytosine 25 mg/kg four times daily for 7-10 days 1
  • For resistant organisms (e.g., Candida krusei and Candida glabrata), AmB-d bladder irrigation may be considered 1

For Severe or Systemic Infections

  • If the infection has spread beyond local tissues or the patient is critically ill:
    • An echinocandin (caspofungin, micafungin, or anidulafungin) is preferred 1, 3
    • Caspofungin: 70 mg loading dose on day 1, followed by 50 mg daily 3
    • Micafungin: 100 mg daily 3
    • Anidulafungin: 200 mg loading dose, then 100 mg daily 3

Special Considerations

  • For patients with renal impairment, dose adjustment of fluconazole may be necessary 1
  • Eliminate predisposing factors when possible, including temporary discontinuation of Jardiance if infection is severe 1
  • For recurrent infections, consider prophylactic antifungal therapy while continuing Jardiance 2
  • Monitor for potential drug interactions, especially if the patient is on multiple medications 4
  • For patients with diabetes, ensure adequate glycemic control as high blood glucose levels can worsen fungal infections 3

Duration of Treatment and Follow-up

  • Treat for at least 14 days for symptomatic infections 1
  • Continue treatment until complete resolution of symptoms 1
  • For recurrent infections, consider longer duration of therapy and investigation of underlying factors 2
  • Follow-up within 1-2 weeks after completing therapy to ensure resolution 1

Common Pitfalls and Caveats

  • Failure to identify the causative organism can lead to inappropriate treatment selection 1
  • Long-term azole use can cause hepatotoxicity and hormone-related effects; monitor for adverse effects 4
  • Inadequate duration of therapy is a common cause of treatment failure and recurrence 1
  • Continuing Jardiance without addressing the fungal infection may lead to persistent or recurrent infections 2
  • Not eliminating predisposing factors (e.g., tight clothing, poor hygiene) can contribute to treatment failure 1

By following this treatment approach, most Jardiance-induced fungal infections can be effectively managed while allowing patients to continue their diabetes therapy if appropriate.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fungal Infections of the Beard Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Approach for Pichia kudriavzevii Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.